{"id":"https://openalex.org/W4361949634","doi":"https://doi.org/10.1158/1078-0432.c.6519678.v1","title":"Data from FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both In Vitro and In Vivo","display_name":"Data from FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both In Vitro and In Vivo","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361949634","doi":"https://doi.org/10.1158/1078-0432.c.6519678.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6519678.v1","doi":"https://doi.org/10.1158/1078-0432.c.6519678.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6519678.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.c.6519678.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086474840","display_name":"Rachel Sharpe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel Sharpe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031626209","display_name":"Alexander T. Pearson","orcid":"https://orcid.org/0000-0003-2801-7456","observed_orcids":["https://orcid.org/0000-0003-2801-7456"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex Pearson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048310310","display_name":"Mar\u00eda Teresa Herrera-Abreu","orcid":"https://orcid.org/0000-0002-6953-3919","observed_orcids":["https://orcid.org/0000-0002-6953-3919"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria T. Herrera-Abreu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114168377","display_name":"Damian Johnson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Damian Johnson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073016473","display_name":"Alan G. Mackay","orcid":"https://orcid.org/0000-0003-3323-4017","observed_orcids":["https://orcid.org/0000-0003-3323-4017"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan Mackay","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009602906","display_name":"Jonathan C. Welti","orcid":"https://orcid.org/0000-0002-9433-8138","observed_orcids":["https://orcid.org/0000-0002-9433-8138"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan C. Welti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057324933","display_name":"Rachael Natrajan","orcid":"https://orcid.org/0000-0002-9987-2946","observed_orcids":["https://orcid.org/0000-0002-9987-2946"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachael Natrajan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103723130","display_name":"Andrew R. Reynolds","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew R. Reynolds","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077235697","display_name":"Jorge Sergio Reis-Filho","orcid":"https://orcid.org/0000-0003-2969-3173","observed_orcids":["https://orcid.org/0000-0003-2969-3173"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jorge S. Reis-Filho","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058973407","display_name":"Alan Ashworth","orcid":"https://orcid.org/0000-0003-1446-7878","observed_orcids":["https://orcid.org/0000-0003-1446-7878","https://orcid.org/0009-0008-8974-2233"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan Ashworth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5060044961","display_name":"Nicholas C. Turner","orcid":"https://orcid.org/0000-0001-8937-0873","observed_orcids":["https://orcid.org/0000-0001-8937-0873"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicholas C. Turner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.013500000350177288,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fgfr-signaling","display_name":"FGFR signaling","score":0.9549999833106995},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9679999947547913},{"id":"https://openalex.org/keywords/basal-like-breast-cancer","display_name":"basal-like breast cancer","score":1.0},{"id":"https://openalex.org/keywords/pd173074","display_name":"PD173074","score":0.9559999704360962},{"id":"https://openalex.org/keywords/fgfr-inhibitors","display_name":"FGFR inhibitors","score":0.8980000019073486},{"id":"https://openalex.org/keywords/fgf2","display_name":"FGF2","score":0.8410000205039978},{"id":"https://openalex.org/keywords/autocrine-signaling","display_name":"autocrine signaling","score":0.8830000162124634},{"id":"https://openalex.org/keywords/mitogen-activated-protein-kinase","display_name":"mitogen-activated protein kinase","score":0.7979999780654907},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.984000027179718},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.8429999947547913},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anchorage-independent-growth","display_name":"anchorage-independent growth","score":0.8560000061988831},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.7739999890327454}],"concepts":[{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.5338640809059143},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5300338864326477},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5083624720573425},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5066159963607788},{"id":"https://openalex.org/C74373430","wikidata":"https://www.wikidata.org/wiki/Q24727126","display_name":"Fibroblast growth factor","level":3,"score":0.45239347219467163},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.4479213058948517},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4287446141242981},{"id":"https://openalex.org/C82867764","wikidata":"https://www.wikidata.org/wiki/Q24780051","display_name":"Fibroblast growth factor receptor","level":4,"score":0.41152840852737427},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.37518030405044556},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.36683225631713867},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.35963910818099976},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3272858262062073},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2691723108291626},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23653653264045715},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.19000911712646484},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08871534466743469}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6519678.v1","doi":"https://doi.org/10.1158/1078-0432.c.6519678.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6519678.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6519678.v1","doi":"https://doi.org/10.1158/1078-0432.c.6519678.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6519678.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2095646155","https://openalex.org/W2327689690","https://openalex.org/W3005850617","https://openalex.org/W1982439765","https://openalex.org/W1993358951","https://openalex.org/W2739705864","https://openalex.org/W2069869200","https://openalex.org/W6981807273","https://openalex.org/W3199973467","https://openalex.org/W2317518443"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"The":[2,104],"oncogenic":[3],"drivers":[4],"of":[5,31,40,53,56,96,106,158,171,181,210],"triple-negative":[6],"(TN)":[7],"and":[8,68,133,136,140,192,226,232],"basal-like":[9,159,184,212],"breast":[10,45,58,77,143,160,173,213,222,227],"cancers":[11,161,174],"are":[12],"largely":[13],"unknown.":[14],"Substantial":[15],"evidence":[16],"now":[17],"links":[18],"aberrant":[19],"signaling":[20,42,135,201],"by":[21,166],"the":[22,29,38,51,63,70,208],"fibroblast":[23],"growth":[24,119,189,209],"factor":[25],"receptors":[26],"(FGFR)":[27],"to":[28,62,84,114,149,235],"development":[30],"multiple":[32],"cancer":[33,59,78,144,214,223],"types.":[34],"Here,":[35],"we":[36],"examined":[37,50],"role":[39],"FGFR":[41,65,115,236],"in":[43,117,124,183,190,218],"TN":[44,76,97,107],"cancer.":[46],"Experimental":[47],"Design:":[48],"We":[49],"sensitivity":[52,113,234],"a":[54,239],"panel":[55],"31":[57],"cell":[60,79,88,98,108,145,185,215,224],"lines":[61,80,89,99,109,146,186],"selective":[64],"inhibitor":[66],"PD173074":[67,85,127,205],"investigated":[69],"potential":[71,240],"mechanisms":[72],"underlying":[73],"sensitivity.":[74],"Results:":[75],"were":[81,121,147],"more":[82],"sensitive":[83,123],"than":[86],"comparator":[87],"(P":[90,175],"=":[91],"0.011),":[92],"with":[93,169,204],"47%":[94],"(7/15)":[95],"showing":[100],"significantly":[101,187,206],"reduced":[102,188,193,207],"growth.":[103],"majority":[105],"showed":[110],"only":[111],"modest":[112],"inhibition":[116],"two-dimensional":[118],"but":[120],"highly":[122],"anchorage-independent":[125],"conditions.":[126],"inhibited":[128],"downstream":[129],"mitogen-activated":[130],"protein":[131],"kinase":[132],"PI3K\u2013AKT":[134],"induced":[137],"cell-cycle":[138],"arrest":[139],"apoptosis.":[141],"Basal-like":[142,221],"found":[148],"express":[150,229],"FGF2":[151,182,200,231],"ligand":[152],"(11/21":[153],"positive)":[154],"and,":[155],"similarly,":[156],"62%":[157],"expressed":[162],"FGF2,":[163],"as":[164],"assessed":[165],"immunohistochemistry":[167],"compared":[168],"5%":[170],"nonbasal":[172],"<":[176],"0.0001).":[177],"RNA":[178],"interference":[179],"targeting":[180],"vitro":[191],"down":[194],"stream":[195],"signaling,":[196],"suggesting":[197],"an":[198],"autocrine":[199,230],"loop.":[202],"Treatment":[203],"CAL51":[211],"line":[216],"xenografts":[217],"vivo.":[219],"Conclusions:":[220],"lines,":[225],"cancers,":[228],"show":[233],"inhibitors,":[237],"identifying":[238],"novel":[241],"therapeutic":[242],"approach":[243],"for":[244],"these":[245],"cancers.":[246],"Clin":[247],"Cancer":[248],"Res;":[249],"17(16);":[250],"5275\u201386.":[251],"\u00a92011":[252],"AACR.":[253]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-04-05T00:00:00"}